Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025
Scientific Industries (OTCQB:SCND), a developer of bioprocessing products and vision-based pill counters, has scheduled its second quarter fiscal year 2025 financial results conference call for August 20, 2025, at 11:00 AM Eastern Time.
The company will file its Form 10Q and release financial results for the quarter ended June 30, 2025, on August 19, 2025. Investors can participate by dialing (844) 481-2706 (domestic) or (412) 317-0662 (international), or via webcast on the company's Investor Relations page. A replay will be available through August 27, 2025.
Scientific Industries (OTCQB:SCND), sviluppatore di prodotti per il bioprocesso e di contatori di pillole basati su visione, ha fissato la conference call sui risultati finanziari del secondo trimestre dell'esercizio 2025 per il 20 agosto 2025 alle 11:00 (Eastern Time).
La società presenterà il modulo Form 10-Q e pubblicherà i risultati finanziari relativi al trimestre chiuso il 30 giugno 2025 il 19 agosto 2025. Gli investitori possono partecipare chiamando il (844) 481-2706 (nazionale) o il (412) 317-0662 (internazionale), oppure tramite webcast nella pagina Investor Relations dell'azienda. La registrazione sarà disponibile fino al 27 agosto 2025.
Scientific Industries (OTCQB:SCND), desarrolladora de productos de bioprocesamiento y contadores de pastillas por visión, ha programado su conferencia telefónica sobre resultados financieros del segundo trimestre del ejercicio 2025 para el 20 de agosto de 2025 a las 11:00 AM, hora del Este.
La compañía presentará el Formulario 10-Q y dará a conocer los resultados financieros del trimestre cerrado el 30 de junio de 2025 el 19 de agosto de 2025. Los inversores pueden participar llamando al (844) 481-2706 (nacional) o al (412) 317-0662 (internacional), o vía webcast en la página de Relaciones con Inversores de la empresa. La repetición estará disponible hasta el 27 de agosto de 2025.
Scientific Industries (OTCQB:SCND)� 바이오프로세� 제품� 비전 기반 알약 계수기를 개발하는 회사�, 2025 회계연도 2분기 실적 콘퍼런스콜을 2025� 8� 20� 동부 표준� 오전 11�� 개최� 예정입니�.
회사� 2025� 6� 30일로 종료� 분기� 실적� 담은 Form 10-Q� 2025� 8� 19일에 제출하고 재무 결과� 발표합니�. 투자자는 국내에서� (844) 481-2706, 해외에서� (412) 317-0662� 전화하거� 회사� 투자� 관� 페이지에서 웹캐스트� 참여� � 있습니다. 재청취는 2025� 8� 27일까지 제공됩니�.
Scientific Industries (OTCQB:SCND), développeur de produits de bioprocédé et de compteurs de comprimés par vision, a programmé sa conférence téléphonique sur les résultats financiers du deuxième trimestre de l'exercice 2025 pour le 20 août 2025 à 11h00, heure de l'Est.
La société déposera son formulaire 10-Q et publiera les résultats financiers du trimestre clos le 30 juin 2025 le 19 août 2025. Les investisseurs peuvent participer en composant le (844) 481-2706 (national) ou le (412) 317-0662 (international), ou via le webcast sur la page Relations Investisseurs de l'entreprise. La rediffusion sera accessible jusqu'au 27 août 2025.
Scientific Industries (OTCQB:SCND), ein Entwickler von Bioprozess-Produkten und bildbasierten Pillenzählern, hat seine Telefonkonferenz zu den Finanzergebnissen des zweiten Quartals des Geschäftsjahres 2025 für den 20. August 2025 um 11:00 Uhr Eastern Time angesetzt.
Das Unternehmen wird seinen Form 10-Q einreichen und die Finanzergebnisse für das Quartal zum 30. Juni 2025 am 19. August 2025 veröffentlichen. Investoren können teilnehmen, indem sie (844) 481-2706 (inland) oder (412) 317-0662 (international) anrufen oder über den Webcast auf der Investor-Relations-Seite des Unternehmens zuschauen. Eine Wiederholung ist bis zum 27. August 2025 verfügbar.
- None.
- None.
Investor Call to be held at 11:00 AM Eastern Time
BOHEMIA, N.Y., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, announced it will file the Form 10Q and issue a press release on August 19, 2025, for its second quarter financial results ended June 30, 2025.
The Company will conduct a conference call for all interested parties on Wednesday, August 20th, at 11:00 a.m. Eastern Time to discuss its financial results.
Conference Call Details
To participate in this call, please dial (844) 481-2706 or (412) 317-0662 (international), or listen via a live webcast, which is available on the Company’s Investor Relations page at or at . A replay of the call will be available through August 27, 2025, at (877) 344-7529 or (412) 317-0088 (international), replay access code: 9616873, or for 30 days at .
About Scientific Industries, Inc.
Scientific Industries (OTCQB: SCND) designs, manufactures, and markets bioprocessing systems under the product name DOTS, vision-based pill counters under the VIVID brand, and weighing products under the Torbal brand. Scientific Industries' products are generally used in R&D laboratories for synthetic biology, and pharmacies and industries requiring weighing products. To learn more, visit .
About Scientific Bioprocessing, Inc.
Scientific Bioprocessing, Inc. ("SBI") is dedicated to pioneering digitally simplified bioprocessing by providing actionable insights from lab to production floor. With a broad portfolio of state-of-the-art bioprocess sensors and actuators as well as innovative data analytics software, SBI helps scientists and engineers in bioprocessing to monitor and control critical process parameters and product quality attributes. SBI is a subsidiary of Scientific Industries Inc. (SCND-OTCQB) To learn more, visit .
Safe Harbor Statement
Statements made during the webcast that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be taken in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-K.
Company Contact: | |
Helena R. Santos | or: |
CEO and President | Joe Dorame |
Phone: 631-567-4700 | Lytham Partners, LLC |
[email protected] | Phone: (602)889-9700 |
[email protected] | [email protected] |
